Washington University School of Medicine: Schizophrenia trials
The registry lists 13 Schizophrenia studies with Washington University School of Medicine as lead sponsor. 2 are open to participants now and 4 have results posted.
Phase 1 1Phase 2 1Phase 4 1No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2Not yet recruitingNCT07875790Not applicable
- Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1RecruitingNCT07853807Not applicable
- Repetitive TMS & Cognitive Training in Adults With SchizophreniaTerminatedNCT03741751Not applicableResults posted
- Glucose and Lipid Metabolism on Antipsychotic MedicationCompletedNCT00515723Not applicableResults posted
- Changes in Adiposity, Metabolic Measures From Atypicals to AripiprazoleCompletedNCT00205660Phase 4Results posted
- Determining Metabolic Effects of Valproate and Antipsychotic TherapyCompletedNCT00167934Not applicableResults posted
- Dasatinib Plus Quercetin for Accelerated Aging in Mental DisordersActive, not recruitingNCT05838560Phase 2
- PET Imaging Study of α7 and α4β2-nAChR in SchizophreniaTerminatedNCT05462340Phase 1
- Effects of Antipsychotic Medications on Energy Intake and ExpenditureCompletedNCT00836251
- Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in SchizophreniaCompletedNCT00552500Not applicable
- Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia PatientsCompletedNCT00501163
- Janssen - Glucose Regulation/Risp/OlanzCompletedNCT00205738Not applicable
- Pfizer/IVGTT/Ziprasidone/OlanzapineCompletedNCT00205725Not applicable